April 2019 FDA Recall Drug by Legacy Pharmaceutical Packaging Llc
D-1263-2019 - CGMP Deviations

This Class II drug recall was voluntarily initiated by Legacy Pharmaceutical Packaging Llc on April 24, 2019 for the product Drug. The FDA reported the reason for recall as cgmp deviations. The product was distributed in TN, AZ and the recall is currently ongoing.

Recall Number: D-1263-2019

Reason for Recall
CGMP Deviations: Detection of trace amounts of N-Methylnitrosobutyric acid (NMBA) impurity found in the Active Pharmaceutical Ingredient (API)
Initiated
04-24-2019
Reported
05-08-2019
Quantity
60,012 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Legacy Pharmaceutical Packaging LLC
Losartan Potassium Tablets, USP, 50 mg, 30 tablet bottles, Rx Only, Distributed by: The Kroger Co, Cincinnati, OH 45202, Manufactured for: Torrent Pharma Inc., 150 Allen Road, Suite 102, Basking Ridge, NJ 07920, Packaged by: Legacy Pharmaceutical Packaging LLC, Earth City, MO 63045 NDC 68645-494-54

Batch or Lot Expiration Information

Lot# Lot 181598; 02/2021